Skip to main navigation Skip to search Skip to main content

Long-Term Oncologic Outcomes of Minimally Invasive Proctectomy for Rectal Adenocarcinoma

  • Amit Merchea*
  • , Shahzad M. Ali
  • , Scott R. Kelley
  • , Emilie Duchalais
  • , Jasim Y. Alabbad
  • , Eric J. Dozois
  • , David W. Larson
  • *Corresponding author for this work
  • Division of Colon and Rectal Surgery
  • Mayo Clinic in Jacksonville, Florida
  • Division of Metabolic & amp; Abdominal Wall Reconstructive Surgery
  • Mayo Clinic Rochester, MN
  • Division of Colon and Rectal Surgery

Research output: Contribution to journal › Article › peer-review

13 Scopus citations

Abstract

Background: Long-term oncologic outcomes after minimally invasive surgery (MIS) for rectal adenocarcinoma compared to open surgery continue to be debated. We aimed to review our high-volume single-institution outcomes in MIS rectal cancer surgery. Methods: A retrospective review of a prospectively collected database was completed of all consecutive adult patients with rectal adenocarcinoma treated from January 2005 through December 2011. Stage IV or recurrent disease was excluded. Demographics and operative and pathologic details were reviewed and reported. Primary endpoints include survival and recurrence. Results: A total of 324 patients were included and median follow-up was 54 months (IQR = 37.0, 78.8). The mean age was 58.2 ± 14.1 years. Tumors were in the upper rectum in 111 patients, mid-rectum in 113 patients, and lower rectum in 100 patients. Stage III disease was most common (49.4%). Overall conversion to open procedure rate was 13.9%. The circumferential radial margin was positive in only 1 patient (0.3%) and the mean lymph node yield was 24.7 ± 17.2. Cancer recurred in 42 patients (13%), 10 (2.5%) patients developed local recurrence, 32 (9.8%) developed distant metastasis, and 2 (0.6%) patients had both. The 5-year overall survival for stage 0, 1, 2, and 3 disease is 96, 91, 80, and 77%, respectively (p = 0.015). Conclusion: In carefully selected rectal cancer patients treated with MIS, long-term outcomes of survival and recurrence appear to compare favorably to previously published series.

Original languageEnglish
Pages (from-to)1412-1417
Number of pages6
JournalJournal of Gastrointestinal Surgery
Volume22
Issue number8
DOIs
StatePublished - 1 Aug 2018
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • MIS
  • Minimally invasive surgery
  • Proctectomy
  • Rectal adenocarcinoma
  • Rectal cancer

Fingerprint

Dive into the research topics of 'Long-Term Oncologic Outcomes of Minimally Invasive Proctectomy for Rectal Adenocarcinoma'. Together they form a unique fingerprint.

Cite this